Pancreatic cancer could be treated with a Parkinson's drug

 

Bhutia Lab

A new study shows that a common drug for Parkinson's disease has anti-cancer effects in mice and human pancreatic cells.

The new research suggests that carbidopa, which is a drug approved by the Food and Drug Administration (FDA) and widely used to treat Parkinson's disease, has significant anti-cancer properties.

Carbidopa is typically used in conjunction with levodopa (L-Dopa) to treat Parkinson's disease. And previous studies have shown that patients with Parkinson's tend to have a lower incidence of cancer.

In older research, scientists investigated whether or not it was the drug L-Dopa that yielded the anti-cancer effect, but they did not find any significant results.

So now, a team led by Dr. Yangzom Bhutia - from the Texas Tech University Health Sciences Center (TTUHSC) in Lubbock - hypothesized that carbidopa alone could have anti-cancer properties.

Commenting on the motivation for the research, Dr. Bhutia says, "Interestingly, no one has previously suspected carbidopa as a potential player in this phenomenon."

"Carbidopa is never used by itself as a drug for any disease," she adds. "But [...] we believe that the reduced incidence of most cancers in Parkinson's disease patients is due to carbidopa."

The first author of the study is Jiro Ogura, of the Department of Cell Biology and Biochemistry at TTUHSC, and the findings were published in the Biochemical Journal.

Article originally published in Medical News Today, www.medicalnewstoday.com

To read full article, please visit https://www.medicalnewstoday.com/articles/319578.php

Related Stories

Summer Program Introduces Medical Students to the Research Laboratory

Each year, approximately 100 first-year TTUHSC School of Medicine students — more than half of the Lubbock class — step out of the classroom and into the laboratory to spend part of their summer making unique discoveries through the Medical Student Summer Research Program (MSSRP).

Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas

The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.

TTUHSC Names New Regional Dean for the School of Nursing

Louise Rice, DNP, RN, has been named regional dean of the TTUHSC School of Nursing on the Amarillo campus.

Recent Stories

Summer Program Introduces Medical Students to the Research Laboratory

Each year, approximately 100 first-year TTUHSC School of Medicine students — more than half of the Lubbock class — step out of the classroom and into the laboratory to spend part of their summer making unique discoveries through the Medical Student Summer Research Program (MSSRP).

Research

TTUHSC Researcher Awarded CPRIT Grant to Study Type of Pediatric Bone Cancer

CPRIT recently awarded a two-year, $198,822 grant to Balakrishna Koneru, Ph.D., an assistant professor of pediatrics at TTUHSC’s School of Medicine and Graduate School of Biomedical Sciences.

Education

From Classroom to Clinic: Building the Future of Speech-Language Pathology

The Clinical Experience Course in the Speech, Language and Hearing Sciences program at TTUHSC provides students with hands-on, practical application of the theoretical knowledge learned in the classroom.